Evidence map›Paper›PMID 38790394›Full record

ArticleBrain sciences2024

A Case Series Study of Weekly or Fortnightly Transcranial Magnetic Stimulation (TMS) in Major Depressive Disorder.

Yvonne Turnier-Shea, Gregory M Peterson, Marzena Rybak, Saxby Pridmore

Abstract read
In one paragraph

Article in Brain sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yvonne Turnier-SheaHobart TMS, Bellerive, TAS 7018, Australia.
Gregory M PetersonSchool of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7001, Australia.ORCID 0000-0002-6764-3882
Marzena RybakHobart TMS, Bellerive, TAS 7018, Australia.
Saxby PridmoreHobart TMS, Bellerive, TAS 7018, Australia.

Funding

UTAS Pharmacy Appeal Nil
6 · The paper itself

Abstract

backgroundMajor depressive disorder (MDD) is frequently chronic and relapsing. The use of maintenance or continuation transcranial magnetic stimulation (TMS) has received clinical and some research support.

objectiveTo conduct a case series study to report the outcomes of once-weekly (OW) or once-fortnightly (OF) continuation TMS in a real-life setting.

methodsWe offered OW or OF TMS sessions to patients with MDD in remission or partial remission/relapse.

resultsTen patients received OW TMS and four received OF TMS, for 8 to 46 weeks. No patients in either group who were in remission or partial remission at baseline experienced a relapse. Improvements in HAMD6 and CGI-S scores were statistically significant or of borderline significance for the total sample and the OW group.

conclusionsThis naturalistic, open-label observational study indicates that OW TMS is effective as maintenance therapy in MDD, while also offering some support for OF TMS maintenance in preventing relapse.

Indexed as

case seriesmaintenance transcranial magnetic stimulationmajor depressive disorderoutcomespreservation transcranial magnetic stimulationtranscranial magnetic stimulation

Identifiers

PMID38790394
PMCPMC11118001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.